Whatis
AELMHU?
We are a non-profit association made up of pharmaceutical companies, specialised in rare diseases, that are committed to discovering, researching, developing and commercialising innovative therapies that improve the lives of patients and their families.
AccessReport
AELMHU prepares, on a quarterly and annual basis,
reports on access to orphan drugs in Spain.
NEWS
NEWS
With the aim of highlighting the benefits of orphan therapies, not only for patients and their families, but also in economic terms for the health system, the document "Differential aspects of orphan therapies" has been presented in ... Read more
Informe de Ensayos Clínicos
en España para 2025
AELMHU at PERTE for
Vanguard Health
II Jornada Formativa para periodistas sobre enfermedades raras
AELMHU within the Strategic Plan of
Pharmaceutical Industry
INTERVIEWS
INTERVIEWS
Día de la Enfermedad de
Células Falciforme
La vida con
Miastenia
ASSOCIATED COMPANIES
RESEARCH AND COMMITMENT to rare diseases
MEMBERS
Do you want to be part of AELMHU?
